Online Media Kit
FEATURED STORY
March 16, 2022 | Times LIVE (South Africa)
More HIV prevention options for SA women as vaginal ring approved
The South African Health Products Regulatory Authority (SAHPRA) okayed the use of the monthly dapivirine vaginal ring by adult women. More »
FEATURED STORY
February 26, 2022 | The East African (Kenya)
Young women prefer vaginal ring to daily oral pill for HIV prevention
Given a choice between two HIV prevention products, most adolescent girls and young women who had used both products while participating in the REACH study chose the monthly dapivirine ring. More »
FEATURED STORY
January 26, 2021 | World Health Organization
WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection
WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »
Media Highlights
July 15, 2020 | Microbicide Trials Network (MTN)
Baby Steps to Giant Strides: MTN’s approach to HIV prevention research with pregnant and breastfeeding women
The increased risk of HIV in these populations is now widely recognized. In 2020, MTN is implementing two studies of the monthly dapivirine vaginal ring and Truvada® as daily PrEP in pregnant and... More »
July 14, 2020 | Daily Trust (Nigeria)
HIV: Nigeria needs national PrEP roadmap to ensure equitable access
The executive director of the New HIV Vaccine and Microbicides Advocacy Society discusses the status of microbicides, oral PrEP, and HIV prevention research. More »
July 08, 2020 | Healio
Researchers highlight importance of youth, women in HIV prevention research
An AIDS 2020 press conference highlighted the importance of involving young people and women, and of alternative HIV prevention methods like the dapivirine ring. More »
July 07, 2020 | AVAC
Injectable PrEP is Highly Effective for Some Populations and Must Move Forward as Quickly as Possible
AVAC welcomes promising HIV prevention results and calls for action to enable access to potential long-acting prevention options like injectable cabotegravir and the dapivirine ring. More »
July 06, 2020 | FHI 360's Degrees blog
Put a ring on it: Four reasons to make the dapivirine ring an HIV prevention option for women and girls
An analysis of interviews with stakeholders in seven sub-Saharan African countries shows widespread enthusiasm for the ring as part of comprehensive HIV prevention programming. More »